SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense downward pressure and widespread investor skepticism following a lackluster earnings report and broader concerns over AI capital expenditure. The community is deeply polarized, with bears pointing to bearish technical breakdowns and executive controversies, while bulls are actively debating whether current levels represent a long-term accumulation opportunity or a value trap.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heavy volatility as investors weigh strong earnings and AI demand against broader concerns regarding rising capital expenditures and macroeconomic pressures. The community remains deeply divided, with some traders viewing the current pullback as a manipulation-driven buying opportunity while others warn of a broader correction in overvalued semiconductor stocks.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors react to China's recent inclusion of the company on its export control list, a move aimed at tightening access to critical dual-use materials. The community remains divided, with some viewing the geopolitical pressure as a long-term validation of the firm's strategic importance for U.S. defense and supply chain independence, while others express frustration over recent stock volatility and the ongoing pressure from short sellers.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is seeing intense market volatility and heavy short interest as investors react to a recent collaboration with GE Aerospace and a strategic pivot toward data center solutions. Community discussion remains polarized, with some traders betting on a significant short squeeze due to high short float, while others express frustration over lingering concerns regarding production capacity, dilution, and the company's past financial restructuring.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

Investors are closely watching TSLL as Tesla's price volatility sparks intense debate over whether to "buy the fear" or brace for further downside, particularly with ongoing discussions around technical support levels and the risks of a reverse split. The community remains deeply polarized, with some bulls emphasizing long-term autonomy and robotics potential while skeptics warn against the punishing effects of leverage decay during high-volatility swings.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is experiencing heightened volatility and community debate as investors navigate a heated proxy battle with the former CEO and track progress on Project Matador. While the stock has seen significant price swings, discussion is primarily focused on the impending announcement of an anchor tenant and the potential for a major re-rating once the company achieves its infrastructure development milestones.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing heightened volatility and intense social media debate as investors weigh the anticipated Starship test flight against significant concerns regarding upcoming share lockup expirations and lofty valuations. The community remains deeply polarized, with bulls pointing to the potential of a successful launch to drive momentum, while bears argue that fundamental headwinds and looming supply increases suggest further downward pressure.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is currently facing significant selling pressure as investors digest a large stock offering while navigating broader sector-wide volatility linked to the recent SpaceX market debut. Despite the pullback, the community remains divided, with some investors highlighting the company's strong revenue growth and long-term satellite data moat, while others express frustration over management's decision to dilute shares during a turbulent time for space stocks.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently attracting significant attention as community members debate whether heavy trading activity and elevated short interest point toward a potential short squeeze or aggressive institutional accumulation. Investors are closely monitoring management's optimistic outlook on second-half performance alongside ongoing discussions regarding a potential strategic partnership, while sentiment remains divided between those betting on fundamental undervaluation and others concerned about debt levels and executive leadership.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors digest the negative CHMP opinion on its lead drug arimoclomol, triggering a sharp sell-off despite the company's plan to request a formal re-examination. While the community is debating whether the rejection stems from regulatory hurdles or presentation issues, many long-term holders are highlighting the company's U.S. revenue, cash position, and ongoing pipeline assets as reasons to potentially buy the dip.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026

TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 PR Newswire ANDOVER, Mass., July 21, 2026 ANDOVER, Mass., July 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX...

TransMedics Completes PAD Aviation Investment to Expand in Europe

TMDX's PAD Aviation investment expands its OCS model into Europe, aiming to boost organ logistics, utilization and adoption.

Where Will TransMedics Group Stock Be in 10 Years?

Where Will TransMedics Group Stock Be in 10 Years...

TMDX Stock Rallies As Analyst Sees 77% Upside  — Here’s Why  

Equity

TD Cowen maintained its ‘Buy’ rating on TransMedics with a $120 price target. 


Reasons to Retain TransMedics Stock in Your Portfolio for Now

TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.

TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?

TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

This Healthcare Infrastructure Stock Is Risky, But the Upside Looks Huge

TransMedics (NASDAQ: TMDX) has been hit hard as investors question margins, spending, and execution. But beneath the sell-off, the company's Organ Care System, aviation network, and National OCS Program could be building a deeper transplant infrastructure moat than the market rea...

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire ANDOVER, Mass., May 21, 2026 ANDOVER, Mass., May 21, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a...

TransMedics to Present at the William Blair 46th Annual Growth Stock Conference

TransMedics to Present at the William Blair 46th Annual Growth Stock Conference TransMedics to Present at the William Blair 46th Annual Growth Stock Conference PR Newswire ANDOVER, Mass., May 19...

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

Bearish Sentiment

Buying - this is temporary noise

Holding existing position

Selling / Trimming / Shorting

Watching from the sidelines

$TMDX is sliding after Stifel flagged a surge in "dry runs.". TransMedics investors are divided: is this a temporary operational blip or a structural crack in the growth story? Cast your vote below.

$TMDX sliding on &quot;dry run&quot; concerns - are you buying this dip?

Stocktwits

 sliding on "dry run" concerns - are you buying this dip?

Current Price	$70.55
Prev Close	$71.13
Open	$72.50
Dividend Yield	0.00%
50-Day Moving Average	$71.03
Beta	1.28
Avg. Volume	1.2M
PE Ratio	16.33

52-Week High	$156.00
52-Week Low	$60.11
Market Capitalization	$2.46B
EPS (Annual)	$4.87
Price to Book	4.97
Revenue Per Employee	$674,269.49

Feed

News

Sentiment

Earnings

Fundamentals

Info

TMDXTransmedics Group Inc

Latest TMDX News